PEAQX

PEAQX is a competitive antagonist of the NMDA receptor, a type of ionotropic glutamate receptor in the brain. It is used in scientific research to help understand the function of NMDA receptors, and has potential therapeutic applications in conditions such as stroke, epilepsy, and neurodegenerative diseases.

Mechanism of Action

PEAQX acts by binding to the glutamate site of the NMDA receptor, preventing the activation of the receptor by glutamate. This inhibits the flow of ions through the receptor, reducing the excitatory synaptic transmission in the brain.

Uses

PEAQX is primarily used in scientific research to study the function of NMDA receptors. It has been used in experiments to investigate the role of these receptors in learning and memory, pain perception, and neurodegeneration.

In addition to its research uses, PEAQX has potential therapeutic applications. It may be useful in the treatment of conditions that are associated with excessive activation of NMDA receptors, such as stroke, epilepsy, and neurodegenerative diseases.

Side Effects

As with any drug, PEAQX can have side effects. These can include nausea, dizziness, and headaches. However, these side effects are generally mild and temporary.

See Also

• NMDA receptor antagonist
• Glutamate receptor
• Neurodegeneration

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia